article thumbnail

TechCrunch+ roundup: Psychedelic biotech, Gogoro’s SPAC, H-1Bs for Ukrainians

TechCrunch

6 questions investors should ask when evaluating psychedelic biotech companies. 6 questions investors should ask when evaluating psychedelic biotech companies. ” Terra will back UST with additional Layer 1 blockchains as it expands its ecosystem, said Kwon. Image Credits: Yarygin (opens in a new window) / Getty Images.

Biotech 222
article thumbnail

The Week’s 10 Biggest Funding Rounds: Scale AI’s Massive $1B Deal Leads Slower Week

Crunchbase News

Nevertheless, the week saw a $1 billion round go to yet another AI startup, and biotech and blockchain also saw some big deals. AltruBio , $225M, biotech: AltruBio was the biggest biotech raise of the week, securing a $225 million Series B led by BVF Partners. Farcaster , $150M, blockchain: Is Web3 funding back?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Week’s 10 Biggest Funding Rounds: Cyera And Monad Labs Raise Massive Rounds In Big Week

Crunchbase News

Monad Labs , $225M, blockchain: New York-based Monad Labs locked up the biggest Web3 funding round of the year thus far, collecting a $225 million funding round led by Paradigm. Monad is a layer-1 blockchain that is compatible with the Ethereum Virtual Machine but can process transactions using the same set of rules faster.

Biotech 104
article thumbnail

The 10 Biggest Rounds Of April: Xaira And Pine Gate Lead Huge Month Of Megadeals

Crunchbase News

April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. A startup needed to raise $200 million or more to break into this list for the April edition. Let’s take a look.

Biotech 110
article thumbnail

The Week’s 10 Biggest Funding Rounds: Wonder Delivers Largest Round Of Week

Crunchbase News

Mirador Therapeutics , $400M, biotech: More big biotech raises this week. Capstan Therapeutics , $175M, biotech: Capstan Therapeutics raised a $175 million Series B led by RA Capital Management. Clasp Therapeutics , $150M, biotech: Clasp Therapeutics is the next biotech to raise huge. billion, per Crunchbase.

Biotech 86
article thumbnail

Investors are sitting on mountains of cash: Where will it be deployed?

TechCrunch

billion in its fourth fund targeting blockchain, bringing its total funds raised for blockchain-related companies to more than $7.6 billion allocated to biotech investments. Founders Fund in March raised over $5 billion across venture ($1.9 billion) and growth ($3.4 billion) funds. a16z in May raised about $4.5

article thumbnail

Crypto-focused Dragonfly Capital launches $650M third fund

TechCrunch

Dragonfly plans to focus its investments across all stages of blockchain and crypto-native companies, protocols, and tokens. “We It’s like investing in crypto without understanding technology is like investing in biotech without understanding biology. You’d be missing the core mechanics of what you’re investing in.”.